Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE

Ohio House to Consider Lethal Injection Drug Bill

By Drug Discovery Trends Editor | December 17, 2014

This undated photo provided by the Ohio House of Representatives shows Rep. Jim Buchy. he Ohio House is expected to consider a bill that would shield the names of companies that provide the state with lethal injection drugs. Buchy is one of the bills sponsors. The bill is among several the House planned to vote on Wednesday, Dec. 17, 2014 as lawmakers finish work for the two-year legislative session. The Senate passed it last week. (AP Photo/Ohio House of Representatives)The names of companies that provide Ohio with lethal injection drugs would be shielded under a proposal the state House is poised to vote on Wednesday.
 
Some lawmakers have said the bill is needed to restart executions in the state. But prosecutors who want a condemned child killer executed in February say the legislation will undoubtedly lead to court challenges, and they’re confident the procedure won’t happen as scheduled.
 
The bill is among several the House planned to vote on as lawmakers finish work for the two-year legislative session.
 
The Senate passed the lethal injection drug bill last week. If the House approves it, the measure would go to Republican Gov. John Kasich.
 
Shielding the names of companies that provide lethal injection drugs is necessary to obtain supplies of the drugs by protecting drugmakers from harassment, according to bill supporters.
 
Problems finding supplies of lethal drugs have created a de facto moratorium on executions in Ohio, which a decade ago was one of the country’s busiest death penalty states.
 
Ohio executed just one inmate this year: Dennis McGuire, who snorted and gasped during much of the 26-minute procedure using a two-drug combo never tried before. Concerns about that execution led to delays of other executions.
 
Opponents of the lethal injection bill say concerns about harassment are overblown and it’s naive to think the bill can truly protect companies’ names from being revealed.
 
The anonymity for companies – which would last 20 years – was requested by lawmakers after prosecutors said executions wouldn’t happen in Ohio without such protection. It’s aimed at compounding pharmacies that mix doses of specialty drugs.
 
Ohio’s first choice of an execution drug is compounded pentobarbital – used frequently in Texas and Missouri – but the state has been unable to obtain it. Its second choice – simultaneous doses of midazolam, a sedative, and hydromorphone, a painkiller – led to McGuire’s prolonged execution and a nearly two-hour-long execution in Arizona in July.
 
In addition, the bill creates a committee to study “the manner and means” of how executions are carried out. At issue is whether other methods already ruled constitutional – such as the electric chair – should be considered. The state abolished electrocution as an option more than a decade ago.
 
The bill also shields the names of participants in Ohio executions.
 

Filed Under: Drug Discovery

 

Related Articles Read More >

If Trump gets Europe to pay more for drugs, more new medicines could follow — eventually
Antibody - visual concept of immune System - 3D illustration
Fresenius picks the biosimilars, WuXi Biologics builds them in a deal covering up to 37 candidates
Physician in a white coat reviewing information on a tablet with a patient in an exam room.
What real-world data shows about current cancer care
Roche Towers, Basel, Switzerland
Roche picks cancer targets, Hansoh builds the ADCs in deal with $400 million upfront
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Drug Delivery Business News
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Pharmaceutical Processing World
  • R&D World
  • Subscribe to our E-Newsletter
  • About Us
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE